Literature DB >> 19543792

Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy.

Marie Douniol1, Aurélia Jacquette, Jean-Marc Guilé, Marie-Laure Tanguy, Nathalie Angeard, Delphine Héron, Monique Plaza, David Cohen.   

Abstract

Myotonic dystrophy type 1 (DM1) is the most frequent inherited neuromuscular disorder. The juvenile form has been associated with cognitive and psychiatric dysfunction, but the phenotype remains unclear. We reviewed the literature to examine the psychiatric phenotype of juvenile DM1 and performed an admixture analysis of the IQ distribution of our own patients, as we hypothesised a bimodal distribution. Two-thirds of the patients had at least one DSM-IV diagnosis, mainly attention deficit/hyperactivity disorder and anxiety disorder. Two-thirds had learning disabilities comorbid with mental retardation on one hand, but also attention deficit, low cognitive speed and visual spatial impairment on the other. IQ showed a bi-modal distribution and was associated with parental transmission. The psychiatric phenotype in juvenile DM1 is complex. We distinguished two different phenotypic subtypes: one group characterised by mental retardation, severe developmental delay and maternal transmission; and another group characterised by borderline full scale IQ, subnormal development and paternal transmission.

Entities:  

Mesh:

Year:  2009        PMID: 19543792     DOI: 10.1007/s00787-009-0037-4

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  55 in total

1.  MYOTONIC DYSTROPHY IN INFANCY AND CHILDHOOD.

Authors:  P R DODGE; I GAMSTORP; R K BYERS; P RUSSELL
Journal:  Pediatrics       Date:  1965-01       Impact factor: 7.124

2.  Intellectual ability as related to age and stage of disease in muscular dystrophy: a brief note.

Authors:  F W Black
Journal:  J Psychol       Date:  1973-07

3.  Dilated Virchow-Robin spaces in myotonic dystrophy: frequency, extent and significance.

Authors:  A Di Costanzo; F Di Salle; L Santoro; V Bonavita; G Tedeschi
Journal:  Eur Neurol       Date:  2001       Impact factor: 1.710

4.  Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy.

Authors:  G Meola; V Sansone; D Perani; A Colleluori; S Cappa; M Cotelli; F Fazio; C A Thornton; R T Moxley
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

5.  Brain MRI features of congenital- and adult-form myotonic dystrophy type 1: case-control study.

Authors:  Alfonso Di Costanzo; Francesco Di Salle; Lucio Santoro; Vincenzo Bonavita; Gioacchino Tedeschi
Journal:  Neuromuscul Disord       Date:  2002-06       Impact factor: 4.296

6.  Cognitive profile in childhood myotonic dystrophy type 1: is there a global impairment?

Authors:  Nathalie Angeard; Marcela Gargiulo; Aurélia Jacquette; Hélène Radvanyi; Bruno Eymard; Delphine Héron
Journal:  Neuromuscul Disord       Date:  2007-04-12       Impact factor: 4.296

7.  Age at onset in bipolar I affective disorder: further evidence for three subgroups.

Authors:  Frank Bellivier; Jean-Louis Golmard; Marcella Rietschel; Thomas G Schulze; Alain Malafosse; Martin Preisig; Patrick McKeon; Lesley Mynett-Johnson; Chantal Henry; Marion Leboyer
Journal:  Am J Psychiatry       Date:  2003-05       Impact factor: 18.112

8.  Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2).

Authors:  G Meola; V Sansone; D Perani; S Scarone; S Cappa; C Dragoni; E Cattaneo; M Cotelli; C Gobbo; F Fazio; G Siciliano; M Mancuso; E Vitelli; S Zhang; R Krahe; R T Moxley
Journal:  Neuromuscul Disord       Date:  2003-12       Impact factor: 4.296

9.  Cognitive function in early adult and adult onset myotonic dystrophy.

Authors:  K P Van Spaendonck; J P Ter Bruggen; E W Weyn Banningh; B A Maassen; J B Van de Biezenbos; F J Gabreëls
Journal:  Acta Neurol Scand       Date:  1995-06       Impact factor: 3.209

10.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

View more
  14 in total

Review 1.  Therapeutics development in myotonic dystrophy type 1.

Authors:  Erin Pennock Foff; Mani S Mahadevan
Journal:  Muscle Nerve       Date:  2011-05-23       Impact factor: 3.217

Review 2.  Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes.

Authors:  Kevin Yum; Eric T Wang; Auinash Kalsotra
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

3.  Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.

Authors:  Guangbin Xia; Yuanzheng Gao; Shouguang Jin; S H Subramony; Naohiro Terada; Laura P W Ranum; Maurice S Swanson; Tetsuo Ashizawa
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

4.  Behavioral Responses in Animal Model of Congenital Muscular Dystrophy 1D.

Authors:  Clarissa M Comim; Aryadnne L Schactae; Jaime A Soares; Letícia Ventura; Viviane Freiberger; Francielle Mina; Diogo Dominguini; Mariz Vainzof; João Quevedo
Journal:  Mol Neurobiol       Date:  2014-12-03       Impact factor: 5.590

Review 5.  Myotonic Dystrophy Type 1 Management and Therapeutics.

Authors:  Cheryl A Smith; Laurie Gutmann
Journal:  Curr Treat Options Neurol       Date:  2016-12       Impact factor: 3.598

6.  Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.

Authors:  Guangbin Xia; Katherine E Santostefano; Marianne Goodwin; Jilin Liu; S H Subramony; Maurice S Swanson; Naohiro Terada; Tetsuo Ashizawa
Journal:  Cell Reprogram       Date:  2013-04       Impact factor: 1.987

Review 7.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

8.  Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review.

Authors:  Johanne Telnes Instanes; Kari Klungsøyr; Anne Halmøy; Ole Bernt Fasmer; Jan Haavik
Journal:  J Atten Disord       Date:  2016-09-01       Impact factor: 3.256

9.  The link between stress disorders and autonomic dysfunction in muscular dystrophy.

Authors:  Rasna Sabharwal
Journal:  Front Physiol       Date:  2014-01-29       Impact factor: 4.566

Review 10.  Core Clinical Phenotypes in Myotonic Dystrophies.

Authors:  Stephan Wenninger; Federica Montagnese; Benedikt Schoser
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.